Stock listing
NASDAQ:CING Cingulate Inc. Stock
Home listing (NASDAQ) of Cingulate Inc.
Follow Cingulate Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CING
$4.51 USD -0.60 (-11.7%)
Close on Nov 20, 2026
- Day range
- $4.40 – $5.24 USDNov 20, 2026
- Volume
- 973,913 sharesNov 20, 2026
- Market cap
- $67.48M USDAt the close on Nov 20, 2026 · price × 14.96M shares outstanding
- 52-week range
- $3.16 – $11.89 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $836,902 USDMedian day 108,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CING · Home | $4.51 USD | -0.60 (-11.7%) | 973,913 | $5.16 | $5.242 | $4.40 | $5.11 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CING · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.51 | -0.60 | -11.7% | $5.16 | $5.242 | $4.40 | 973,913 | |
| $5.11 | +0.39 | +8.3% | $4.94 | $5.485 | $4.81 | 950,344 | |
| $4.72 | +0.97 | +25.9% | $4.30 | $4.93 | $4.05 | 1,611,893 | |
| $3.75 | -0.55 | -12.8% | $4.25 | $4.25 | $3.653 | 479,641 | |
| $4.30 | -0.19 | -4.2% | $4.44 | $4.60 | $4.18 | 188,371 | |
| $4.49 | -0.15 | -3.2% | $4.53 | $4.63 | $4.40 | 72,359 | |
| $4.64 | +0.08 | +1.8% | $4.50 | $4.75 | $4.33 | 139,100 | |
| $4.56 | +0.11 | +2.5% | $4.55 | $4.845 | $4.465 | 195,400 | |
| $4.45 | +0.19 | +4.5% | $4.32 | $4.465 | $4.245 | 56,800 | |
| $4.26 | +0.02 | +0.5% | $4.25 | $4.34 | $4.225 | 103,700 | |
| $4.24 | -0.32 | -7.0% | $4.55 | $4.57 | $4.22 | 146,500 | |
| $4.56 | -0.16 | -3.4% | $4.75 | $4.85 | $4.481 | 110,800 | |
| $4.72 | -0.31 | -6.2% | $4.99 | $5.00 | $4.645 | 179,300 | |
| $5.03 | +0.05 | +1.0% | $4.96 | $5.142 | $4.90 | 107,700 | |
| $4.98 | -0.21 | -4.0% | $5.04 | $5.10 | $4.84 | 76,700 | |
| $5.19 | -0.06 | -1.1% | $5.18 | $5.24 | $5.09 | 38,800 | |
| $5.25 | -0.28 | -5.1% | $5.38 | $5.445 | $4.93 | 211,800 | |
| $5.53 | +0.35 | +6.8% | $5.17 | $5.676 | $5.17 | 294,800 | |
| $5.18 | +0.20 | +4.0% | $5.10 | $5.27 | $5.00 | 229,800 | |
| $4.98 | +0.32 | +6.9% | $4.64 | $4.98 | $4.605 | 79,900 | |
| $4.66 | 0.00 | 0.0% | $4.60 | $4.822 | $4.60 | 77,900 | |
| $4.66 | +0.13 | +2.9% | $4.53 | $4.70 | $4.50 | 132,400 | |
| $4.53 | +0.17 | +3.9% | $4.37 | $4.635 | $4.24 | 108,400 | |
| $4.36 | 0.00 | 0.0% | $4.35 | $4.48 | $4.26 | 47,600 | |
| $4.36 | -0.03 | -0.7% | $4.39 | $4.44 | $4.12 | 228,600 | |
| $4.39 | -0.18 | -3.9% | $4.55 | $4.575 | $4.28 | 175,800 | |
| $4.57 | -0.15 | -3.2% | $4.66 | $4.77 | $4.562 | 105,300 | |
| $4.72 | -0.12 | -2.5% | $4.85 | $4.94 | $4.675 | 73,200 | |
| $4.84 | -0.05 | -1.0% | $4.81 | $4.889 | $4.81 | 30,200 | |
| $4.89 | +0.01 | +0.2% | $4.87 | $4.975 | $4.77 | 27,800 | |
| $4.88 | +0.01 | +0.2% | $4.84 | $4.98 | $4.75 | 75,700 | |
| $4.87 | -0.02 | -0.4% | $4.82 | $4.96 | $4.67 | 115,600 | |
| $4.89 | +0.14 | +2.9% | $4.75 | $5.00 | $4.75 | 111,400 | |
| $4.75 | -0.01 | -0.2% | $4.82 | $4.905 | $4.63 | 139,800 | |
| $4.76 | +0.01 | +0.2% | $4.79 | $4.904 | $4.705 | 52,100 | |
| $4.75 | -0.20 | -4.0% | $4.95 | $4.95 | $4.735 | 48,800 | |
| $4.95 | +0.045 | +0.9% | $4.91 | $5.02 | $4.82 | 66,300 | |
| $4.905 | +0.085 | +1.8% | $4.88 | $4.97 | $4.837 | 66,600 | |
| $4.82 | -0.01 | -0.2% | $4.97 | $4.97 | $4.59 | 171,900 | |
| $4.83 | -0.23 | -4.5% | $5.01 | $5.12 | $4.80 | 147,500 | |
| $5.06 | +0.08 | +1.6% | $5.015 | $5.07 | $4.81 | 82,500 | |
| $4.98 | -0.165 | -3.2% | $5.10 | $5.22 | $4.93 | 118,200 | |
| $5.145 | -0.085 | -1.6% | $5.26 | $5.35 | $5.125 | 78,100 | |
| $5.23 | -0.01 | -0.2% | $5.27 | $5.48 | $5.21 | 75,500 | |
| $5.24 | +0.09 | +1.7% | $5.11 | $5.28 | $5.09 | 83,200 | |
| $5.15 | +0.06 | +1.2% | $5.17 | $5.19 | $5.00 | 124,400 | |
| $5.09 | -0.02 | -0.4% | $5.16 | $5.21 | $5.09 | 76,700 | |
| $5.11 | -0.06 | -1.2% | $5.16 | $5.21 | $5.03 | 58,900 | |
| $5.17 | +0.15 | +3.0% | $5.00 | $5.19 | $4.80 | 101,200 | |
| $5.02 | -0.15 | -2.9% | $5.22 | $5.28 | $5.02 | 99,600 | |
| $5.17 | -0.04 | -0.8% | $5.17 | $5.41 | $5.155 | 117,500 | |
| $5.21 | +0.02 | +0.4% | $5.24 | $5.40 | $5.16 | 72,500 | |
| $5.19 | +0.09 | +1.8% | $5.09 | $5.28 | $5.05 | 76,400 | |
| $5.10 | -0.12 | -2.3% | $5.21 | $5.498 | $5.02 | 107,000 | |
| $5.22 | +0.07 | +1.4% | $5.19 | $5.27 | $5.06 | 82,000 | |
| $5.15 | +0.04 | +0.8% | $5.14 | $5.25 | $5.11 | 83,300 | |
| $5.11 | -0.06 | -1.2% | $5.16 | $5.215 | $5.03 | 70,500 | |
| $5.17 | -0.155 | -2.9% | $5.33 | $5.33 | $5.02 | 202,100 | |
| $5.325 | -0.115 | -2.1% | $5.48 | $5.49 | $5.256 | 108,400 | |
| $5.44 | +0.04 | +0.7% | $5.50 | $5.60 | $5.37 | 150,600 | |
| $5.40 | -0.47 | -8.0% | $5.86 | $5.86 | $5.36 | 157,800 | |
| $5.87 | +0.19 | +3.3% | $5.71 | $5.94 | $5.65 | 165,700 | |
| $5.68 | +0.13 | +2.3% | $5.51 | $5.93 | $5.335 | 279,800 | |
| $5.55 | +0.22 | +4.1% | $5.35 | $5.55 | $5.18 | 230,800 | |
| $5.33 | +0.06 | +1.1% | $5.21 | $5.38 | $5.037 | 131,600 |
Splits
2 splits since 2023 · NASDAQ:CING · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-12 | Consolidation | |
| 1-for-20 | Consolidation |
- Ticker
- NASDAQ:CING
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Cingulate Announces U.S. Patent Issuance for CTx-2103, Further Validating PTR™ Technology Platform
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 29 slides
Latest news
Cingulate Announces U.S. Patent Issuance for CTx-2103, Further Validating PTR™ Technology Platform
Nov 19, 2026
Closed $4.51 (-11.7%) on Nov 20, 2026
Cingulate Inc. Reports Third Quarter 2026 Financial Results and Provides Regulatory Update on CTx-1301 NDA Resubmission
Nov 13, 2026
Closed $3.75 (-12.8%) on Nov 16, 2026
Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King
Nov 10, 2026
Closed $4.56 (+2.5%) on Nov 10, 2026
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Sep 17, 2026
Closed $5.15 (+1.2%) on Sep 17, 2026
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
Aug 13, 2026
Closed $4.99 (-4.2%) on Aug 13, 2026
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
Aug 11, 2026
Closed $5.20 (-1.0%) on Aug 11, 2026
Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
Jul 30, 2026
Closed $4.76 (+5.2%) on Jul 30, 2026
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
Jul 2, 2026
Closed $5.38 (-8.7%) on Jul 2, 2026
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
Jun 16, 2026
Closed $4.74 (-3.9%) on Jun 16, 2026
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26
Jun 4, 2026
Closed $4.80 (-1.6%) on Jun 4, 2026
Cingulate Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 77 in all · newest Nov 19, 2026 · oldest 2021
- Decks
- 11 decks · latest October 2026
Where Cingulate Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CING · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CING | BOATS | United States | USD |
Valuation
Price/book 3.3× against a median of 3.0×: 7th lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.21B USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 3.3×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 56.0×
- Beta vs S&P 500
- 1.41
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cingulate Inc. · NASDAQ:CING | US$67.48M | US$1.21B | n/a | n/a | n/a | 3.3× | n/a | 56.0× | 1.41 |
| Coya Therapeutics, Inc. · NASDAQ:COYA | US$69.20M | US$33.40M | n/a | 7.1× | n/a | 2.1× | −643.5% | 0.0× | 1.64 |
| MAIA Biotechnology, Inc. · AMEX:MAIA | US$68.54M | US$68.54M | n/a | n/a | n/a | 4.7× | n/a | 0.0× | 1.62 |
| ABIONYX Pharma SA · EURONEXT:ABNX | US$68.36M | US$55.53M | n/a | 12.4× | n/a | 4.0× | −136.6% | 1.0× | n/a |
| Energenesis Biomedical Co., Ltd. · TWSE:6657 | US$67.22M | US$47.02M | n/a | 203× | n/a | 3.1× | n/a | 0.0× | n/a |
| MediciNova, Inc. · NASDAQ:MNOV | US$67.11M | US$38.45M | n/a | 41.1× | n/a | 1.6× | n/a | 0.0× | 0.56 |
| Dicot Pharma AB · OMXSTO:DICOT | US$66.56M | US$44.51M | n/a | n/a | n/a | 3.0× | n/a | 0.0× | n/a |
| Cardiff Oncology, Inc. · NASDAQ:CRDF | US$66.34M | US$32.82M | n/a | 58.7× | n/a | 2.4× | n/a | 0.0× | 1.32 |
| Polaryx Therapeutics, Inc. · NASDAQ:PLYX | US$66.30M | US$57.86M | n/a | n/a | n/a | 8.7× | n/a | 0.0× | 1.66 |
| PMV Pharmaceuticals, Inc. · NASDAQ:PMVP | US$66.17M | −US$36.25M | n/a | n/a | n/a | 1.2× | n/a | 0.0× | 1.43 |
| Gossamer Bio, Inc. · NASDAQ:GOSS | US$65.57M | US$55.23M | n/a | 0.7× | n/a | n/a | −159.5% | n/a | 1.56 |
| Median of the others | US$66.84M | US$45.76M | 26.8× | 3.0× | −159.5% | 0.0× | 1.56 |
Forecasts
3 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.
- Price target
- 21.20 USD · Analysts' mean
- EPS, year to Dec 2026
- -2.19 · 4 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Shane J. Schaffer | Chairman and Chief Executive Officer |
| Jennifer Callahan | Chief Financial Officer |
| Thomas Dalton | Vice President, Corporate and Government Relations |
| Bryan Downey | Chief Commercial Officer |
| Matthew Brams | Chief Medical Officer |
| Raul R. Silva | Chief Science Officer |
Board
| Director | Role |
|---|---|
| Shane J. Schaffer | Chairman and Chief Executive Officer |
| Bryan Lawrence | Director |
| Frederick Jiang | Director |
| Jeff Hargroves | Director |
| Peter J. Werth | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 13, 2026 · After close | −12.8% |
| Q2 2026 | Aug 13, 2026 · Before open | −4.2% |
| Q1 2026 | May 14, 2026 · Before open | −10.8% |
| Q4 2025 | Mar 18, 2026 | −35.6% |
| Q3 2025 | Nov 13, 2025 · After close | +4.8% |
| Q2 2025 | Aug 19, 2025 · Before open | −9.6% |
| Q1 2025 | May 8, 2025 · After close | −2.0% |
| Q4 2024 | Mar 27, 2025 | +5.1% |
| Q3 2024 | Nov 7, 2024 · Before open | +2.4% |
| Q2 2024 | Aug 13, 2024 · Before open | −21.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 1, 2024 · Before open | −0.9% |
| Q4 2023 | Mar 31, 2024 · After close | −0.9% |
| Q3 2023 | Nov 13, 2023 · After close | −3.2% |
| Q2 2023 | Aug 14, 2023 · After close | +12.3% |
| Q1 2023 | May 10, 2023 · After close | −3.7% |
| Q4 2022 | Mar 10, 2023 · After close | −28.6% |
| Q3 2022 | Nov 14, 2022 · Before open | −2.9% |
| Q2 2022 | Aug 11, 2022 · Before open | −9.7% |
| Q1 2022 | May 12, 2022 · After close | +15.7% |
| Q4 2021 | Mar 10, 2022 · Before open | −9.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2026) | Investor deck | 29 slides | October 2026 |
| Investor Presentation (2026) | Investor deck | 26 slides | 2026 |
| Technical Presentation (2025) | Technical | 10 slides | 2025 |
| Investor Presentation (October 2023) | Investor deck | 30 slides | Oct 19, 2023 |
| Investor Presentation (January 2023) | Investor deck | 21 slides | Jan 9, 2023 |
| Corporate Update (November 2022) | Corporate update | 21 slides | Nov 14, 2022 |
| Investor Presentation (October 2022) | Investor deck | 20 slides | Oct 25, 2022 |
| Investor Presentation (September 2022) | Investor deck | 21 slides | Sep 12, 2022 |
| Investor Presentation (May 2022) | Investor deck | 24 slides | May 12, 2022 |
| Investor Presentation (April 2022) | Investor deck | 26 slides | Apr 20, 2022 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (February 2022) | Investor deck | 20 slides | Feb 8, 2022 |
Financings
| Raise | Date |
|---|---|
| Private placement of preferred stock and warrants (PIPE) Closed: US$12M raised · US$5.04 a share · 80% warrant coverage; warrants exercisable upon stockholder approval; three-year term Buyers: Falcon Creek Capital Advisor LLC (Affiliates led the PIPE; received right to designate up to two board members); Jeff Hargroves (significant participant in the PIPE financing) Insiders: The transaction included insider participation; former board member and board designee Jeff Hargroves was a significant participant. Use of proceeds: General operations ahead of the commercial launch of CTx-1301, subject to FDA approval | Feb 17, 2026 |
| Non-convertible, unsecured promissory note Closed: US$6M raised Use of proceeds: Working capital and other general corporate purposes | Nov 10, 2025 |
| Non-convertible, unsecured promissory note Closed: US$5M raised Use of proceeds: Working capital and other general corporate purposes | Dec 23, 2024 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$6.00 a unit on Dec 7, 2021.
- Price
- US$6.00 a unit
- Units offered
- 4,166,666 units
- Offering size
- US$25 million
- Underwriters' option
- Up to 624,999 more units
- Listing
- CING on the Nasdaq Capital Market
- Underwriters
- Aegis Capital Corp., Laidlaw & Company (UK) Ltd. · In the order on the cover
- Units delivered
- On or about Dec 10, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 24, 2021 |
| Filed publicly | Sep 9, 2021 |
| Amended 5 times | Newest Nov 30, 2021 |
| Shares registered with an exchange | Oct 4, 2021 |
| Declared effective by the SEC | Dec 7, 2021 |
| Final prospectus, with the price | Dec 9, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Dec 9, 2021 |
| EFFECT · Notice that a registration is effective | Dec 7, 2021 |
| CERT · Exchange's certificate of listing | Dec 6, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Dec 3, 2021 |
| CORRESP · Letter to the SEC | Dec 3, 2021 |
| CORRESP · Letter to the SEC | Dec 3, 2021 |
| S-1/A · Registration statement, amended | Nov 30, 2021 |
| S-1/A · Registration statement, amended | Nov 10, 2021 |
| CORRESP · Letter to the SEC | Oct 14, 2021 |
| CORRESP · Letter to the SEC | Oct 14, 2021 |
All 33 filings
Open IPO · From the cover of the final prospectus (424B4) filed Dec 9, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 540.9K | 653.1K | 582.9K | 622.0K | 808.4K | 842.4K | 178.9K |
| Gross profit | -540.9K | -653.1K | -582.9K | -622.0K | -808.4K | -842.4K | -178.9K |
| Research and development | 9.77M | 9.45M | 15.5M | 9.00M | 8.41M | 5.09M | 9.09M |
| Selling, general and administrative | 10.2M | 6.20M | 7.27M | 8.51M | 12.3M | 1.99M | 2.30M |
| Operating income | -19.9M | -15.6M | -22.8M | -17.5M | -20.7M | -7.08M | -11.6M |
| Depreciation and amortization | 540.9K | 653.1K | 582.9K | 394.0K | 708.3K | 666.0K | 178.9K |
| EBITDA | -19.4M | -15.0M | -22.2M | -17.1M | -20.0M | -6.42M | -11.5M |
| Interest expense | 901.3K | 25.4K | 790.0K | 292.3K | 33.4K | 54.6K | 0 |
| Income before tax | -22.4M | -16.6M | -23.5M | -17.7M | -20.7M | -7.18M | -11.5M |
| Income tax | -263 | 2 | 174.0K | 30.5K | 99.3K | -100.5K | |
| Net income | -22.4M | -16.6M | -23.5M | -17.7M | -20.7M | -7.18M | -11.5M |
| Earnings per share, basic | -4.44 | -10.86 | -311.99 | -29.35 | -2.79 | -0.64 | -8.17 |
| Earnings per share, diluted | -4.44 | -10.86 | -311.99 | -29.35 | -2.79 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.0M | 12.2M | 52.4K | 5.36M | 16.5M | 1.20M | 418.5K |
| Short-term investments | 0 | 933 | 933 | 18.7K | |||
| Receivables | 8.01K | 26.3K | 14.6K | 234.4K | 690.2K | 151.8K | 113.2K |
| Inventory | -54.9K | -14.6K | 100.3K | -689.3K | |||
| Current assets | 12.0M | 12.7M | 578.6K | 7.87M | 18.9M | 1.79M | 978.3K |
| Property, plant and equipment | 1.73M | 2.10M | 2.55M | 2.90M | 3.15M | 3.04M | 4.16M |
| Total assets | 15.1M | 14.9M | 3.49M | 11.4M | 22.9M | 5.79M | 5.28M |
| Accounts payable | 2.04M | 1.27M | 5.20M | 762.4K | 264.7K | 975.1K | 1.90M |
| Current liabilities | 10.3M | 4.97M | 10.2M | 7.01M | 1.18M | 3.36M | 2.95M |
| Long-term debt | 1.15M | 2.44M | |||||
| Total debt | 8.79M | 5.10M | 3.51M | 5.87M | 1.18M | 2.05M | 2.09M |
| Total liabilities | 12.6M | 7.41M | 10.4M | 7.52M | 2.04M | 4.50M | 4.66M |
| Shareholders' equity | 2.51M | 7.46M | -6.87M | 3.88M | 20.8M | 1.29M | 615.9K |
| Shares outstanding | 7.25M | 3.40M | 97.3K | 602.6K | 11.3M | 11.3M | 1.41M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -17.2M | -18.5M | -15.0M | -15.9M | -10.4M | -6.81M | -9.53M |
| Capital spending | -162.1K | -211.8K | -224.1K | -153.4K | -814.7K | -402.1K | -1.02M |
| Free cash flow | -17.4M | -18.7M | -15.3M | -16.0M | -11.2M | -7.21M | -10.5M |
| Cash from investing | -162.1K | -211.8K | -224.1K | -152.7K | -814.7K | -384.2K | 2.74M |
| Cash from financing | 16.1M | 30.8M | 9.95M | 4.90M | 26.5M | 7.97M | 6.14M |
| Change in cash | -1.26M | 12.2M | -5.30M | -11.1M | 15.3M | 779.2K | -644.7K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2026 | Results | SEC |
| 424B3 · Prospectus | Nov 13, 2026 | Offer document | SEC |
| 8-K · Current report | Nov 10, 2026 | Current report | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 2, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| 8-K · Current report | Jul 23, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jul 15, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 14, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 2, 2026 | Management or board change | SEC |
| 8-K · Current report | Jun 16, 2026 | Current report | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 8, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 2, 2026 | Current report | SEC |
| DEF 14A · Proxy statement | May 29, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | May 29, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | May 29, 2026 | Meeting notice | SEC |
| 8-K · Current report | May 19, 2026 | Management or board change | SEC |
| PRE 14A · Preliminary proxy statement | May 19, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 14, 2026 | Results | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 424B3 · Prospectus | Apr 28, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Apr 27, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Apr 22, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Apr 17, 2026 | Other filings | SEC |
| S-3 · Registration statement | Apr 14, 2026 | Offer document | SEC |
| 8-K · Current report | Apr 2, 2026 | Management or board change | SEC |
| 424B3 · Prospectus | Mar 27, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Mar 27, 2026 | Other filings | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| CORRESP · Letter to the SEC | Mar 26, 2026 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Mar 25, 2026 | Other filings | SEC |
| 8-K · Current report | Mar 24, 2026 | Material contract | SEC |
| 424B3 · Prospectus | Mar 24, 2026 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Mar 24, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 23, 2026 | Other filings | SEC |
| S-3/A · Registration statement, amended | Mar 23, 2026 | Offer document | SEC |
| S-3 · Registration statement | Mar 19, 2026 | Offer document | SEC |
| DEFA14A · Additional proxy material | Mar 18, 2026 | Meeting notice | SEC |
| 10-K · Annual report | Mar 18, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 18, 2026 | Results | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| DEF 14A · Proxy statement | Mar 2, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Feb 18, 2026 | Meeting notice | SEC |
| 8-K · Current report | Feb 17, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| SCHEDULE 13D · Big-stake notice | Feb 9, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Feb 6, 2026 | Financing | SEC |
| 8-K · Current report | Jan 28, 2026 | Material contract | SEC |
| 8-K · Current report | Jan 15, 2026 | Current report | SEC |
| UPLOAD · Letter from the SEC | Jan 14, 2026 | Other filings | SEC |
| S-3 · Registration statement | Jan 12, 2026 | Offer document | SEC |
| 424B5 · Prospectus | Jan 12, 2026 | Offer document | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 2, 2026 | Financing | SEC |
| 8-K · Current report | Dec 15, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2025 | Results | SEC |
| 4 · Change in ownership | Nov 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 10, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 10, 2025 | Material contract | SEC |
| 8-K · Current report | Oct 14, 2025 | Current report | SEC |
| 8-K · Current report | Sep 25, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Sep 5, 2025 | Financing | SEC |
| 8-K · Current report | Aug 28, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 19, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 19, 2025 | Results | SEC |
| DEF 14A · Proxy statement | Aug 15, 2025 | Meeting notice | SEC |
| NT 10-Q · Late filing notice | Aug 15, 2025 | Explanation request | SEC |
| 8-K · Current report | Aug 15, 2025 | Management or board change | SEC |
| 8-K · Current report | Aug 8, 2025 | Management or board change | SEC |
| 8-K · Current report | Aug 6, 2025 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Aug 5, 2025 | Meeting notice | SEC |
| 424B3 · Prospectus | Jul 30, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 30, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 25, 2025 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Jul 25, 2025 | Offer document | SEC |
| S-1/A · Registration statement, amended | Jul 25, 2025 | Offer document | SEC |
| 8-K · Current report | Jul 25, 2025 | Financing | SEC |
| UPLOAD · Letter from the SEC | Jul 24, 2025 | Other filings | SEC |
| S-1 · Registration statement | Jul 22, 2025 | Offer document | SEC |
| 8-K · Current report | Jul 22, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jul 10, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 23, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 11, 2025 | Management or board change | SEC |
| 8-K · Current report | May 13, 2025 | Current report | SEC |
| 10-Q · Quarterly report | May 8, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 8, 2025 | Results | SEC |
| DEFA14A · Additional proxy material | Apr 28, 2025 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 25, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 25, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 15, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 9, 2025 | Material contract | SEC |
| 10-K · Annual report | Mar 27, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 26, 2025 | Results | SEC |
| 8-K · Current report | Mar 4, 2025 | Current report | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 3, 2025 | Current report | SEC |
| 8-K · Current report | Jan 24, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Jan 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 7, 2025 | Current report | SEC |
| 8-K · Current report | Dec 23, 2024 | Material contract | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2024 | Results | SEC |
| 8-K · Current report | Oct 15, 2024 | Current report | SEC |
| 424B5 · Prospectus | Oct 15, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 8, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Oct 7, 2024 | Offer document | SEC |
| S-1/A · Registration statement, amended | Oct 7, 2024 | Offer document | SEC |
| 8-K · Current report | Oct 7, 2024 | Current report | SEC |
| 8-K · Current report | Oct 4, 2024 | Current report | SEC |
| CORRESP · Letter to the SEC | Oct 3, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Oct 3, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Oct 2, 2024 | Other filings | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| S-1 · Registration statement | Sep 27, 2024 | Offer document | SEC |
| 8-K · Current report | Sep 12, 2024 | Management or board change | SEC |
| 8-K · Current report | Sep 10, 2024 | Current report | SEC |
| 424B5 · Prospectus | Sep 3, 2024 | Offer document | SEC |
| 8-K · Current report | Sep 3, 2024 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 30, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Aug 29, 2024 | Current report | SEC |
| 8-K · Current report | Aug 28, 2024 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | Aug 28, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Aug 27, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Aug 26, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 26, 2024 | Other filings | SEC |
| DEFA14A · Additional proxy material | Aug 23, 2024 | Meeting notice | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 20, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 19, 2024 | Insider trade | SEC |
| S-1 · Registration statement | Aug 19, 2024 | Offer document | SEC |
| 8-K · Current report | Aug 19, 2024 | Current report | SEC |
| 424B5 · Prospectus | Aug 19, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2024 | Results | SEC |
| 8-K · Current report | Aug 7, 2024 | Current report | SEC |
| 8-K · Current report | Jul 30, 2024 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | Jul 25, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Jul 24, 2024 | Offer document | SEC |
| DEF 14A · Proxy statement | Jul 22, 2024 | Meeting notice | SEC |
| CORRESP · Letter to the SEC | Jul 22, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 22, 2024 | Other filings | SEC |
| SC 13D/A · Big-stake notice, amended | Jul 16, 2024 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Jul 15, 2024 | Offer document | SEC |
| S-3 · Registration statement | Jul 15, 2024 | Offer document | SEC |
| PRE 14A · Preliminary proxy statement | Jul 12, 2024 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jul 12, 2024 | Meeting notice | SEC |
| SC 13D/A · Big-stake notice, amended | Jul 2, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Jul 1, 2024 | Material contract | SEC |
| DEF 14A · Proxy statement | Jun 28, 2024 | Meeting notice | SEC |
| SC 13D/A · Big-stake notice, amended | Jun 27, 2024 | Big-stake notice | SEC |
| PRE 14A · Preliminary proxy statement | Jun 18, 2024 | Meeting notice | SEC |
| 8-K · Current report | Jun 18, 2024 | Current report | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
This page holds 200 of 497 filings. Open Filings
Cap table
Built by 6ix from Cingulate Inc.’s releases · as of Nov 13, 2026
- Common shares
- 14,963,080
- Fully diluted
- 14,963,080
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 14,963,080 | Nov 13, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · expire about Feb 2029 |
Share count over time
| Count | Shares |
|---|---|
| Nov 13, 2026 | 14,963,080 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gregg Wm Givens Other companies: DST Systems Inc (Sr VP, CFO & Treasurer · Jun 15, 2016 – Apr 16, 2018 · Past) | Director · Dec 7, 2021 – Jun 15, 2023 · Past |
| Jeffrey S Ervin Other companies: Allarity Therapeutics, Inc. (CFO · Since at least Jul 1, 2025) | Director · Since at least Feb 12, 2024 |
| Jeffrey X Conroy Other companies: Odyssey Health Inc. (Director · Aug 28, 2019 – May 19, 2022 · Past) | Director · Dec 7, 2021 – Feb 25, 2022 · Past |
| Patrick Joseph Gallagher Other companies: Streamex Corp. (Director · Dec 28, 2021 – Aug 15, 2023 · Past) | Director · Jun 15, 2023 – Jun 15, 2023 · Past |
| Bryan Downey | Chief Commercial Officer · Since at least Nov 3, 2025 |
| Bryan Lawrence | Director · Since at least Nov 5, 2026 |
| Craig S Gilgallon | EVP and General Counsel · Dec 7, 2021 – Feb 28, 2023 · Past |
| Frederick Jiang | Director · Since at least Feb 17, 2026 |
| Jeff Hargroves | Director · Since at least Mar 18, 2026 |
| Jennifer Callahan | EVP and CFO · Since at least Dec 7, 2021 |
All 18 people
| Person | Seat |
|---|---|
| Laurie Myers | EVP and COO · Since at least Dec 7, 2021 |
| Louis G Van Horn | EVP and CFO · Dec 7, 2021 – Feb 28, 2023 · Past |
| Matthew Brams | Chief Medical Officer · Since at least Mar 4, 2024 |
| Peter J. Werth | Director · Since at least Nov 5, 2026 |
| Raul R. Silva | EVP and CSO · Since at least Dec 7, 2021 |
| Shane J. Schaffer | Chief Executive Officer, Director · Since at least Dec 7, 2021 |
| Thomas Dalton | Vice President, Corporate and Government Relations · Since at least May 14, 2026 |
| Thomas Jeffrey Hargroves | Director · Since at least Feb 13, 2026 |
Log in to ask 6ix AI your own questions about Cingulate Inc.